Package 0472-0082-16

{"route": ["ORAL"], "spl_id": "6f58843b-1a91-42b4-b03c-7cad93c931d6", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0304720082163"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["a4c1305c-f18c-4fb0-83d8-2822341f2dfa"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (0472-0082-16)", "package_ndc": "0472-0082-16", "marketing_start_date": "20020903"}], "brand_name": "Acyclovir", "product_id": "0472-0082_6f58843b-1a91-42b4-b03c-7cad93c931d6", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "0472-0082", "generic_name": "Acyclovir", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA074738", "marketing_category": "ANDA", "marketing_start_date": "20020903", "listing_expiration_date": "20271231"}